Price movement over the last 24 hours
Align Technology, Inc. vs ArcelorMittal SA — how do they compare? Align Technology, Inc. trades at $179.45 (market cap $12.86B), while ArcelorMittal SA trades at $66.55 (market cap $49.99B). The key difference: ArcelorMittal SA is far larger — about 3.9× Align Technology, Inc.'s market cap, and ArcelorMittal SA pays a 0.91% dividend while Align Technology, Inc. pays none. Which is the better fit depends on your goals.
| ALGN | MT | |
|---|---|---|
Market Cap | $12.86B | $49.99B |
Sector | Health | Basic Materials |
52-Week High | $207.19 | $71.65 |
52-Week Low | $124.88 | $30.39 |
Enterprise Value | $11.92B | $59.31B |
Dividend Yield | — | 0.91% |
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
ArcelorMittal (MT) trades at $66.08, up 4.96% today, with strong earnings beats in recent quarters. The stock shows bullish momentum with a 41% gain over six months, supported by record iron ore shipments and strategic expansions. Valuation ratios appear reasonable with P/E at 17.3 and P/B below 1. Technical indicators are mixed, with moving averages bullish but oscillators neutral. Recent news highlights CEO transitions in Europe and a new share buyback program.
Outlook remains positive due to operational strength and shareholder returns, but risks include heavy capital expenditure and China demand weakness. Analyst consensus is bullish with 50% buy ratings. The stock's performance hinges on continued execution amid global steel market volatility.
Trailing returns across standard periods
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →ArcelorMittal SA is involved in the steel industry. The company's operating segments include NAFTA
Read more on MT →